Format

Send to

Choose Destination
Lancet Diabetes Endocrinol. 2019 Sep 2. pii: S2213-8587(19)30265-7. doi: 10.1016/S2213-8587(19)30265-7. [Epub ahead of print]

NICE guidance on dapagliflozin with insulin for type 1 diabetes.

Author information

1
National Institute for Health and Care Excellence, London SW1A 2BU, UK; Addenbrooke's Hospital, Cambridge, UK. Electronic address: amanda.adler@nice.org.uk.
2
National Institute for Health and Care Excellence, London SW1A 2BU, UK.
3
School of Health and Related Research, University of Sheffield, Sheffield, UK.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center